CD79A and cranioectodermal dysplasia: To compare the anti‐transglutaminase responses in patients with untreated CeD and DH, we assessed binding of serum IgA and IgG to TG2 or TG3 by enzyme‐linked immunosorbent assay (ELISA) (Figure1A,B).